Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2021-02-01 Regulatory Filings
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings
2021-02-01 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC by Caladrius Biosciences, Inc. It is a registration statement under the Securities Act of 1933 for the resale of shares by selling stockholders. The document includes details about the securities being registered, the offering, risk factors, and other related information typical of a registration statement prospectus. It is not an annual report, earnings release, or any other financial report. It is specifically a capital markets filing related to securities registration and offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or notice, supporting a high confidence level.
2021-01-29 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated January 29, 2021. It includes a Regulation FD Disclosure about a slide presentation to be used at investor and industry conferences, attached as Exhibit 99.1. The document explicitly states that the presentation is furnished and not filed, and it is not incorporated by reference into other filings. The content is primarily an announcement of the presentation material rather than the presentation itself or a detailed financial report. The document length is 3703 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Investor Presentation (IP) type, as it relates to a corporate presentation for investors and industry conferences.
2021-01-29 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or corporate changes. The content describes a Private Placement transaction where the company issued shares and warrants to investors, including details about the Securities Purchase Agreement, registration rights, and placement agent fees. This is a clear update on the company's financing activities. There are no financial statements or comprehensive financial data presented, so it is not an Annual Report, Interim Report, or Earnings Release. The document is not a proxy, governance, or management report. It is specifically about a capital raising event and related agreements. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing event, supporting a high confidence score.
2021-01-25 English
FORM 4
Director's Dealing
2021-01-15 English
FORM 4
Director's Dealing
2021-01-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.